Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (68)	7/31/1998 11:25:00 AM
From: Bob Davis	Respond to of 315

Ariella, I believe that you are referring to Shimizu Kenji, who exercised a substantial number of options in March, and concurrently sold sufficient stock to allow him to pay for the options exercised. As a result, Mr. Kenji appears to have added an additional 10,000 shares to his portfolio. This is very common and should not be seen as an indication that an insider is "dumping" the stock. Bob Davis The Napeague Letter napeague.com

To: Ariella who wrote (68)	7/31/1998 11:33:00 AM
From: Bob Davis	Read Replies (4) \| Respond to of 315

Ariella, By the way, CLZR was written up in this morning's Wall Street Journal in its "Thursday's Market Activity" report: "Candela moved up 15/16, or 29%, to 4 3/16, as it earned 19 cents a share in its fourth quarter, compared with a loss of 24 cents in the year-earlier period. The company also said it has eliminated the adverse impact on its earnings from its skin-care center." This will clearly generate more interest in the stock, as its "market awareness" has been relatively low. I participated in yesterday's Analysts Conference Call with the Company, and I now feel that the fourth quarter earnings can be sustained into the future. Although the Company will not have its 10-K Report out for over a month, I plan to update the in-depth Analysis as soon as possible. Bob Davis The Napeague Letter napeague.com